NCT04182360View on ClinicalTrials.gov

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

April 27, 2023

Study Completion Date

April 28, 2023

Conditions
Postpartum HemorrhageTwin
Interventions
DRUG

Carbetocin

Carbetocin administered intravenously, over 1 minute following delivery of the fetal head.

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT04182360 - Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy. | Biotech Hunter | Biotech Hunter